Maruo Calcium Co., Ltd.

As of March 31, 2026, Maruo Calcium Co., Ltd. carries a market capitalization of 3.01B, placing it among publicly traded companies globally. Its enterprise value stands at 2.99B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Maruo Calcium Co., Ltd.'s next confirmed earnings release is scheduled for November 10, 2026.

As of March 31, 2026, Maruo Calcium Co., Ltd. has 2.13M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, Maruo Calcium Co., Ltd. maintains a current ratio of 2.65, meaning it holds 2.6x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2026.

As of the close on October 23, 2026, Maruo Calcium Co., Ltd.'s stock has gained approximately 4.44% over the past 52 weeks. The 50-day moving average sits at 1,448.30, while the 200-day moving average is 1,436.22.

As of March 31, 2026, Maruo Calcium Co., Ltd. holds 2.65B in cash and equivalents against 2.42B in total debt, resulting in a net debt position of -233.15M. Total book value stands at 10.08B, with working capital of 5.49B providing operational flexibility.

Maruo Calcium Co., Ltd.'s most recent stock split took place on September 28, 2016 with a 5:1 split ratio.